Early Stage Prostate Cancer Cohort
NCT00011349 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1116
Last updated 2013-04-15
Summary
Environmental factors such as diet and cigarette smoking may play a role in predicting the progression of early stage prostate cancer to advance disease. The goal of this project is to establish an observational cohort of patients with early stage prostate cancer who elect not to undergo radical prostatectomy or radiation therapy to evaluate risk factors which predict the transformation of early stage to clinically aggressive disease.
Conditions
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Principal Investigators
-
Michael J. Gaziano, MD MOH · VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-01-31
- Primary Completion
- 2006-06-30
- Completion
- 2010-01-31
Countries
- United States
Study Locations
More Related Trials
-
Prostate Cancer Prospective Cohort
NCT00937586 ·Status: ACTIVE_NOT_RECRUITING
-
Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage
NCT06505356 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate Cancer
NCT00739791 ·Status: COMPLETED ·Phase: NA
-
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
NCT02380274 ·Status: COMPLETED
-
Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy
NCT03860961 ·Status: COMPLETED ·Phase: NA
-
Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy
NCT00148772 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
NCT00132301 ·Status: COMPLETED ·Phase: PHASE3
-
Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery
NCT00977457 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer
NCT03290508 ·Status: TERMINATED
-
Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer
NCT01734681 ·Status: WITHDRAWN ·Phase: PHASE2
-
Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression
NCT05683964 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
NCT02008058 ·Status: COMPLETED
-
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
NCT05586360 ·Status: RECRUITING ·Phase: PHASE2
-
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
NCT00455624 ·Status: COMPLETED
-
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
NCT05751434 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active Surveillance
NCT03502213 ·Status: COMPLETED
-
CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer
NCT00075192 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY
NCT02269982 ·Status: COMPLETED
-
Surgery in Treating Patients With Prostate Cancer
NCT00002938 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer
NCT00385580 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II, Dose Finding Study of GTx-758
NCT01393119 ·Status: TERMINATED ·Phase: PHASE2
-
Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
NCT01727154 ·Status: TERMINATED
-
Molecular Mechanisms Underlying Prostate Cancer Disparities
NCT02229565 ·Status: COMPLETED
-
Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy
NCT00133900 ·Status: UNKNOWN
-
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
NCT01325311 ·Status: COMPLETED ·Phase: PHASE2